Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer

Affiliations

• ¹ Department of Urology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
• ² Division of Hematology/Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
• ³ Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.
• ⁴ Division of Biostatistics, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA.
• ⁵ Department of Radiation Oncology and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.
• ⁶ Division of Hematology and Oncology, Irvine Medical Center, University of California, Orange, CA.
• ⁷ Department of Radiation Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA.
• ⁸ Division of Biostatistics, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA. Electronic address: steven.seyedin@ucsf.edu.